目的 分析2014-2016年宜昌市中心人民医院麻醉药品的使用情况。方法 对2014-2016年宜昌市中心人民医院麻醉药品的销售金额、临床用途、使用量、用药频度（DDDs）、排序比（B/A）、限定日费用（DDC）及药物利用指数（DUI）等进行统计学分析。结果 2014-2016年麻醉药品的销售金额逐年上升，2015、2016年的增长幅度较大；销售金额居首位的是注射用盐酸瑞芬太尼，其次是枸橼酸芬太尼注射液、磷酸可待因片；DDDs排序居前列的包括盐酸哌替啶注射液、枸橼酸芬太尼注射液及磷酸可待因片；枸橼酸芬太尼注射液、盐酸吗啡注射液的B/A在2016年趋近于1.0；DDC值排序居前列的包括注射用盐酸瑞芬太尼和枸椽酸舒芬太尼注射液；磷酸可待因片、盐酸哌替啶注射液及芬太尼透皮贴剂的DUI均≤ 1。结论 宜昌市中心人民医院麻醉药品的使用较为合理，基本符合WHO推荐的《癌症三阶梯止痛指导原则》的要求。

Objective To analyze the use of narcotic drugs in Yichang Central People's Hospital from 2014 to 2016. Methods The consumption sum, clinical applications, amounts, frequency of drug use (DDDs), order ratio (B/A), defined daily cost (DDC), and drug utility index (DUI) of narcotic drugs in Yichang Central People's Hospital from 2014 to 2016 were calculated and analyzed. Results Consumption sum of narcotic drugs increased year by year from 2014 to 2016, and the growth rate in 2015 and 2016 was larger. Consumption sum of Remifentanil Hydrochloride for injection ranked the first, followed by Fentanyl Citrate Injection and Codeine Phosphate Tablets. DDDs of Pethidine Hydrochloride Injection, Remifentanil Hydrochloride for injection and Codeine Phosphate Tablets ranked the top. B/A of Remifentanil Hydrochloride for injection and Morphine Hydrochloride Injection in 2016 were near to 1.0. DDC of Morphine Hydrochloride Injection and Citrafter Sufentanil Injection were listed in the forefront. DUI of Codeine Phosphate Tablets, Pethidine Hydrochloride Injection, and Fentanyl Transdermal Patches were lower than 1. Conclusion The use of narcotic drugs in Yichang Central People's Hospital is reasonable, which is in accordance with the requirements of WHO's "Guidelines for Three-step Stimulation of Cancer".